| Breast Cancer |
1 |
1 |
| Breast |
0 |
0.54 |
| Tumor |
0 |
0.54 |
| Cancer |
0 |
0.46 |
| Selective Estrogen Receptor Modulators |
0 |
0.36 |
| Lymph Node |
0 |
0.23 |
| Thromboembolism |
0 |
0.2 |
| Hormonal Therapy |
0 |
0.15 |
| Receptors |
0 |
0.15 |
| Estrogen |
0 |
0.13 |
| Contraception |
0 |
0.12 |
| Social Determinants of Health |
0 |
0.12 |
| Adjuvant Therapy |
0 |
0.08 |
| Bone |
0 |
0.08 |
| Diversity |
0 |
0.08 |
| Mammogram |
0 |
0.08 |
| Progestin |
0 |
0.08 |
| Shared Decision-Making |
0 |
0.08 |
| Venous Thromboembolism (VTE) |
0 |
0.08 |
| Weakness |
0 |
0.08 |